|
Gene: DAAM1 |
Gene summary for DAAM1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | DAAM1 | Gene ID | 23002 |
Gene name | dishevelled associated activator of morphogenesis 1 | |
Gene Alias | DAAM1 | |
Cytomap | 14q23.1 | |
Gene Type | protein-coding | GO ID | GO:0001736 | UniProtAcc | Q9Y4D1 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23002 | DAAM1 | CA_HPV_2 | Human | Cervix | CC | 8.82e-05 | 2.63e-01 | 0.0391 |
23002 | DAAM1 | CCI_1 | Human | Cervix | CC | 1.53e-06 | 8.24e-01 | 0.528 |
23002 | DAAM1 | CCI_2 | Human | Cervix | CC | 1.05e-05 | 8.69e-01 | 0.5249 |
23002 | DAAM1 | CCI_3 | Human | Cervix | CC | 2.86e-02 | 4.75e-01 | 0.516 |
23002 | DAAM1 | Tumor | Human | Cervix | CC | 1.41e-19 | 5.40e-01 | 0.1241 |
23002 | DAAM1 | sample3 | Human | Cervix | CC | 5.98e-36 | 6.78e-01 | 0.1387 |
23002 | DAAM1 | T3 | Human | Cervix | CC | 8.22e-32 | 6.49e-01 | 0.1389 |
23002 | DAAM1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.49e-10 | -4.61e-01 | 0.0155 |
23002 | DAAM1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 6.39e-04 | -5.08e-01 | -0.1207 |
23002 | DAAM1 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.63e-06 | -3.20e-01 | -0.1464 |
23002 | DAAM1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.21e-05 | -3.23e-01 | 0.3859 |
23002 | DAAM1 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.56e-02 | -4.75e-01 | 0.2585 |
23002 | DAAM1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.73e-16 | -5.18e-01 | 0.3005 |
23002 | DAAM1 | A015-C-203 | Human | Colorectum | FAP | 6.11e-24 | -9.49e-02 | -0.1294 |
23002 | DAAM1 | A015-C-204 | Human | Colorectum | FAP | 1.32e-03 | -1.65e-01 | -0.0228 |
23002 | DAAM1 | A002-C-201 | Human | Colorectum | FAP | 2.38e-11 | -2.83e-01 | 0.0324 |
23002 | DAAM1 | A002-C-203 | Human | Colorectum | FAP | 9.96e-03 | -1.72e-01 | 0.2786 |
23002 | DAAM1 | A001-C-119 | Human | Colorectum | FAP | 1.06e-03 | -2.38e-01 | -0.1557 |
23002 | DAAM1 | A001-C-108 | Human | Colorectum | FAP | 2.72e-15 | -1.31e-01 | -0.0272 |
23002 | DAAM1 | A002-C-205 | Human | Colorectum | FAP | 7.52e-16 | -1.75e-01 | -0.1236 |
Page: 1 2 3 4 5 6 7 8 9 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00160557 | Cervix | CC | Wnt signaling pathway | 98/2311 | 444/18723 | 4.82e-09 | 4.65e-07 | 98 |
GO:01987387 | Cervix | CC | cell-cell signaling by wnt | 98/2311 | 446/18723 | 6.16e-09 | 5.58e-07 | 98 |
GO:00017384 | Cervix | CC | morphogenesis of a polarized epithelium | 22/2311 | 94/18723 | 2.09e-03 | 1.52e-02 | 22 |
GO:00901752 | Cervix | CC | regulation of establishment of planar polarity | 14/2311 | 56/18723 | 6.93e-03 | 3.74e-02 | 14 |
GO:00600712 | Cervix | CC | Wnt signaling pathway, planar cell polarity pathway | 13/2311 | 52/18723 | 9.09e-03 | 4.60e-02 | 13 |
GO:0016055 | Colorectum | AD | Wnt signaling pathway | 130/3918 | 444/18723 | 1.60e-05 | 3.37e-04 | 130 |
GO:0198738 | Colorectum | AD | cell-cell signaling by wnt | 130/3918 | 446/18723 | 2.02e-05 | 4.10e-04 | 130 |
GO:0001738 | Colorectum | AD | morphogenesis of a polarized epithelium | 31/3918 | 94/18723 | 4.30e-03 | 2.95e-02 | 31 |
GO:00160552 | Colorectum | MSS | Wnt signaling pathway | 124/3467 | 444/18723 | 6.06e-07 | 2.26e-05 | 124 |
GO:01987382 | Colorectum | MSS | cell-cell signaling by wnt | 124/3467 | 446/18723 | 7.83e-07 | 2.77e-05 | 124 |
GO:00160553 | Colorectum | FAP | Wnt signaling pathway | 104/2622 | 444/18723 | 4.92e-08 | 3.92e-06 | 104 |
GO:01987383 | Colorectum | FAP | cell-cell signaling by wnt | 104/2622 | 446/18723 | 6.26e-08 | 4.54e-06 | 104 |
GO:00017381 | Colorectum | FAP | morphogenesis of a polarized epithelium | 23/2622 | 94/18723 | 4.64e-03 | 3.14e-02 | 23 |
GO:00160554 | Colorectum | CRC | Wnt signaling pathway | 88/2078 | 444/18723 | 3.91e-08 | 5.28e-06 | 88 |
GO:01987384 | Colorectum | CRC | cell-cell signaling by wnt | 88/2078 | 446/18723 | 4.85e-08 | 6.04e-06 | 88 |
GO:2000027 | Colorectum | CRC | regulation of animal organ morphogenesis | 24/2078 | 125/18723 | 5.12e-03 | 3.92e-02 | 24 |
GO:001605516 | Esophagus | HGIN | Wnt signaling pathway | 83/2587 | 444/18723 | 2.27e-03 | 2.33e-02 | 83 |
GO:019873816 | Esophagus | HGIN | cell-cell signaling by wnt | 83/2587 | 446/18723 | 2.58e-03 | 2.55e-02 | 83 |
GO:001605517 | Esophagus | ESCC | Wnt signaling pathway | 268/8552 | 444/18723 | 2.32e-10 | 6.58e-09 | 268 |
GO:019873817 | Esophagus | ESCC | cell-cell signaling by wnt | 269/8552 | 446/18723 | 2.41e-10 | 6.79e-09 | 269 |
Page: 1 2 3 4 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa043109 | Cervix | CC | Wnt signaling pathway | 43/1267 | 171/8465 | 3.03e-04 | 1.64e-03 | 9.68e-04 | 43 |
hsa0431012 | Cervix | CC | Wnt signaling pathway | 43/1267 | 171/8465 | 3.03e-04 | 1.64e-03 | 9.68e-04 | 43 |
hsa04310 | Colorectum | AD | Wnt signaling pathway | 56/2092 | 171/8465 | 1.03e-02 | 3.93e-02 | 2.51e-02 | 56 |
hsa043101 | Colorectum | AD | Wnt signaling pathway | 56/2092 | 171/8465 | 1.03e-02 | 3.93e-02 | 2.51e-02 | 56 |
hsa043102 | Colorectum | MSS | Wnt signaling pathway | 53/1875 | 171/8465 | 4.24e-03 | 1.86e-02 | 1.14e-02 | 53 |
hsa043103 | Colorectum | MSS | Wnt signaling pathway | 53/1875 | 171/8465 | 4.24e-03 | 1.86e-02 | 1.14e-02 | 53 |
hsa043104 | Colorectum | FAP | Wnt signaling pathway | 46/1404 | 171/8465 | 3.94e-04 | 3.06e-03 | 1.86e-03 | 46 |
hsa043105 | Colorectum | FAP | Wnt signaling pathway | 46/1404 | 171/8465 | 3.94e-04 | 3.06e-03 | 1.86e-03 | 46 |
hsa043106 | Colorectum | CRC | Wnt signaling pathway | 40/1091 | 171/8465 | 1.01e-04 | 1.57e-03 | 1.07e-03 | 40 |
hsa043107 | Colorectum | CRC | Wnt signaling pathway | 40/1091 | 171/8465 | 1.01e-04 | 1.57e-03 | 1.07e-03 | 40 |
hsa043108 | Lung | IAC | Wnt signaling pathway | 40/1053 | 171/8465 | 4.56e-05 | 7.06e-04 | 4.69e-04 | 40 |
hsa0431011 | Lung | IAC | Wnt signaling pathway | 40/1053 | 171/8465 | 4.56e-05 | 7.06e-04 | 4.69e-04 | 40 |
hsa0431021 | Lung | AIS | Wnt signaling pathway | 39/961 | 171/8465 | 1.29e-05 | 3.32e-04 | 2.12e-04 | 39 |
hsa0431031 | Lung | AIS | Wnt signaling pathway | 39/961 | 171/8465 | 1.29e-05 | 3.32e-04 | 2.12e-04 | 39 |
hsa0431016 | Oral cavity | EOLP | Wnt signaling pathway | 37/1218 | 171/8465 | 6.23e-03 | 1.83e-02 | 1.08e-02 | 37 |
hsa0431017 | Oral cavity | EOLP | Wnt signaling pathway | 37/1218 | 171/8465 | 6.23e-03 | 1.83e-02 | 1.08e-02 | 37 |
hsa0431024 | Oral cavity | NEOLP | Wnt signaling pathway | 34/1112 | 171/8465 | 8.05e-03 | 2.88e-02 | 1.81e-02 | 34 |
hsa0431034 | Oral cavity | NEOLP | Wnt signaling pathway | 34/1112 | 171/8465 | 8.05e-03 | 2.88e-02 | 1.81e-02 | 34 |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DAAM1 | SNV | Missense_Mutation | novel | c.238N>A | p.Glu80Lys | p.E80K | Q9Y4D1 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-BB-A5HU-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR |
DAAM1 | SNV | Missense_Mutation | c.2289N>C | p.Glu763Asp | p.E763D | Q9Y4D1 | protein_coding | tolerated(0.27) | probably_damaging(0.912) | TCGA-CN-5374-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
DAAM1 | SNV | Missense_Mutation | novel | c.1705C>G | p.Leu569Val | p.L569V | Q9Y4D1 | protein_coding | tolerated(0.52) | benign(0.013) | TCGA-CN-6023-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | erbitux | SD |
DAAM1 | SNV | Missense_Mutation | novel | c.2305N>T | p.His769Tyr | p.H769Y | Q9Y4D1 | protein_coding | deleterious(0) | possibly_damaging(0.775) | TCGA-CQ-5331-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
DAAM1 | SNV | Missense_Mutation | novel | c.587C>A | p.Ala196Asp | p.A196D | Q9Y4D1 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CQ-7063-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
DAAM1 | SNV | Missense_Mutation | novel | c.2426N>T | p.Ala809Val | p.A809V | Q9Y4D1 | protein_coding | deleterious(0.04) | possibly_damaging(0.636) | TCGA-CV-7427-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
DAAM1 | SNV | Missense_Mutation | novel | c.1447N>G | p.Met483Val | p.M483V | Q9Y4D1 | protein_coding | deleterious(0.03) | possibly_damaging(0.761) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
DAAM1 | insertion | Nonsense_Mutation | novel | c.2541_2542insCACATAAAAACATGATTACCAAGTGT | p.Ser848HisfsTer5 | p.S848Hfs*5 | Q9Y4D1 | protein_coding | TCGA-CV-A45T-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
DAAM1 | SNV | Missense_Mutation | novel | c.18A>C | p.Arg6Ser | p.R6S | Q9Y4D1 | protein_coding | deleterious(0) | possibly_damaging(0.879) | TCGA-V1-A8ML-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
DAAM1 | SNV | Missense_Mutation | c.560N>T | p.Ala187Val | p.A187V | Q9Y4D1 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |